Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5' CpG island in endometriosis.

CONTEXT Endometriosis is an estrogen-dependent disease. Steroidogenic factor-1 (SF-1), a transcriptional factor essential for activation of multiple steroidogenic genes for estrogen biosynthesis, is undetectable in normal endometrial stromal cells and aberrantly expressed in endometriotic stromal cells. OBJECTIVE The objective of the study was to unravel the mechanism for differential SF-1 expression in endometrial and endometriotic stromal cells. DESIGN We identified a CpG island flanking the SF-1 promoter and exon I region and determined its methylation patterns in endometrial and endometriotic cells. SETTING The study was conducted at Northwestern University. PATIENTS OR OTHER PARTICIPANTS Eutopic endometrium from disease-free subjects (n = 8) and the walls of cystic endometriosis lesions of the ovaries (n = 8) were investigated. INTERVENTION(S) Stromal cells were isolated from these two types of tissues. MAIN OUTCOME MEASURE(S) Measures are mentioned in Results. RESULTS SF-1 mRNA and protein levels in endometriotic stromal cells were significantly higher than those in endometrial stromal cells (P < 0.001). Bisulfite sequencing showed strikingly increased methylation in endometrial cells, compared with endometriotic cells (P < 0.001). Demethylation by 5-aza-2'-deoxycytidine increased SF-1 mRNA levels by up to 55.48-fold in endometrial cell (P < 0.05). Luciferase assays showed that the -85/+239 region bearing the CpG island regulated its activity (P < 0.01). Natural or in vitro methylation of this region strikingly reduced SF-1 promoter activity in both cell types (P < 0.01). Chromatin immunoprecipitation assay showed that methyl-CpG-binding domain protein 2 binds to the SF-1 promoter in endometrial but not endometriotic cells. CONCLUSIONS This is the first demonstration of methylation-dependent regulation of SF-1 in any mammalian tissue. These findings point to a new mechanism for targeting local estrogen biosynthesis in endometriosis.

[1]  H. Handa,et al.  A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. , 1992, The Journal of biological chemistry.

[2]  S. Bulun,et al.  Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. , 1999, Molecular endocrinology.

[3]  Y. Kitaoka,et al.  Endometriosis: the pathophysiology as an estrogen-dependent disease , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  K. Parker,et al.  Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. , 1992, Molecular endocrinology.

[5]  S. Bulun,et al.  Aromatase inhibitors: the next generation of therapeutics for endometriosis? , 2006, Fertility and sterility.

[6]  A. Bird,et al.  Effects of DNA methylation on DNA-binding proteins and gene expression. , 1993, Current opinion in genetics & development.

[7]  R. Sekhon,et al.  Epigenetic Modifications of Distinct Sequences of the p1 Regulatory Gene Specify Tissue-Specific Expression Patterns in Maize , 2007, Genetics.

[8]  K. Parker,et al.  The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. , 1995, Molecular endocrinology.

[9]  S. Bulun,et al.  Aromatase and other steroidogenic genes in endometriosis: translational aspects. , 2006, Human reproduction update.

[10]  I. Leav,et al.  Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. , 2004, The American journal of pathology.

[11]  B. Schimmer,et al.  Steroidogenic factor 1: a key determinant of endocrine development and function. , 1997, Endocrine reviews.

[12]  S. Bulun,et al.  Role of aromatase in endometrial disease , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  S. Bulun,et al.  Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment , 2005, Pharmacological Reviews.

[14]  P. Mellon,et al.  The basic helix-loop-helix, leucine zipper transcription factor, USF (upstream stimulatory factor), is a key regulator of SF-1 (steroidogenic factor-1) gene expression in pituitary gonadotrope and steroidogenic cells. , 1998, Molecular endocrinology.

[15]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[16]  S. S. Smith.  Biological implications of the mechanism of action of human DNA (cytosine-5)methyltransferase. , 1994, Progress in nucleic acid research and molecular biology.

[17]  K. Parker,et al.  A shared promoter element regulates the expression of three steroidogenic enzymes. , 1991, Molecular endocrinology.

[18]  S. Bulun,et al.  Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. , 1997, The Journal of clinical endocrinology and metabolism.

[19]  A. Borczuk,et al.  Epigenetic inactivation of Betaig-h3 gene in human cancer cells. , 2006, Cancer research.

[20]  W. Shen,et al.  The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. , 1994, Genes & development.

[21]  Y. Bang,et al.  Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells. , 2001, Cancer research.

[22]  Rudolf Jaenisch,et al.  Role for DNA methylation in genomic imprinting , 1993, Nature.

[23]  Hiroshi Honda,et al.  Crucial Roles of Sp1 and Epigenetic Modifications in the Regulation of the CLDN4 Promoter in Ovarian Cancer Cells* , 2006, Journal of Biological Chemistry.

[24]  P. Wade.  Methyl CpG‐binding proteins and transcriptional repression * , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[25]  L. Heckert,et al.  Expression of Steroidogenic Factor 1 in the Testis Requires an E Box and CCAAT Box in its Promoter Proximal Region1 , 2000, Biology of reproduction.

[26]  J. Kitawaki,et al.  Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. , 1997, Biology of reproduction.

[27]  R. Singal,et al.  Methylation of the minimal promoter of an embryonic globin gene silences transcription in primary erythroid cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W. Miller,et al.  Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StARProceedings of Xth International Congress on Hormonal Steroids, Quebec, Canada, 17–21 June 1998. , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[29]  Satoshi Tanaka,et al.  DNA Methylation-dependent Epigenetic Regulation of Dimethylarginine Dimethylaminohydrolase 2 Gene in Trophoblast Cell Lineage* , 2006, Journal of Biological Chemistry.

[30]  R. Jaenisch,et al.  DNA methylation, genomic imprinting, and mammalian development. , 1993, Cold Spring Harbor symposia on quantitative biology.

[31]  I. Ryan,et al.  Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. , 1994, The Journal of clinical endocrinology and metabolism.

[32]  K. Robertson,et al.  Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoter , 1997, Journal of virology.

[33]  A. Bird,et al.  MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.

[34]  H. Nawata,et al.  An E Box Element Is Required for the Expression of the ad4bp Gene, a Mammalian Homologue of ftz-f1 Gene, Which Is Essential for Adrenal and Gonadal Development (*) , 1995, The Journal of Biological Chemistry.

[35]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[36]  M. Ehrlich,et al.  Effect of site-specific DNA methylation and mutagenesis on recognition by methylated DNA-binding protein from human placenta. , 1986, Nucleic acids research.

[37]  S. Bulun,et al.  Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. , 2002, The Journal of clinical endocrinology and metabolism.

[38]  Luyang Sun,et al.  Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis , 2005, Nature.

[39]  A. Bird,et al.  Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.

[40]  A. Razin,et al.  DNA methylation from embryo to adult. , 1994, Progress in nucleic acid research and molecular biology.

[41]  H. Ingraham,et al.  Regulation of the Orphan Nuclear Receptor Steroidogenic Factor 1 by Sox Proteins , 2002 .